🔓 Unlock the full profile of Neil Kumar (Bridgebio), including verified contact details, financial insights, and professional associations.
See Neil Kumar Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: nei*****@bri******.com
Mobile: 93988*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Neil Kumar is the CEO and Founder of BridgeBio, a biopharmaceutical company based in San Francisco, California, established in 2014.
- Under Neil Kumar's leadership, BridgeBio focuses on developing medicines for genetic diseases and cancer, with a commitment to addressing unmet medical needs.
- BridgeBio is publicly traded under the symbol BBIO on the Nasdaq, indicating its growth and established presence in the biotechnology sector.
- As of now, BridgeBio has achieved a market capitalization of approximately $6.6 billion, reflecting its significant impact and value in the biopharmaceutical industry.
- During Neil Kumar's tenure, BridgeBio has experienced substantial growth, marked by a 281.9% increase in headcount over the past twelve months, showcasing the company's expansion efforts.
- Before founding BridgeBio, Neil Kumar held key positions including Principal at Third Rock Ventures and Interim Vice President of Business Development at MyoKardia, gaining valuable experience in the biotechnology field.
- Neil Kumar also served as an Associate Principal at McKinsey & Company, where strategic insights and business acumen were developed that would later contribute to the success of BridgeBio.
- BridgeBio's mission to transform the lives of patients through innovative therapies is directly influenced by the strategic vision and leadership of Neil Kumar.